Stocks
Corcept Therapeutics Incorporated (CORT) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 36.2% | 36.9% | 34.0% | 28.0% | 22.5% | 23.0% | ||
| Changes by years, y/y, % | -1pp | +1pp | -3pp | -6pp | -6pp | -8.8% | |||
Corcept Therapeutics Incorporated. EBITDA margin, %
Corcept Therapeutics Incorporated. EBITDA margin, changes, pp
Corcept Therapeutics Incorporated (CORT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 25.2% | 23.8% | 20.2% | 21.7% | 25.8% | 23.0% | |
| Changes by years, y/y, % | -7pp | +2pp | +6pp | -4pp | +1pp | |||
| Changes by quarters, q/q, % | -1pp | -1pp | -4pp | +2pp | +4pp | |||
